Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients

Exclusion Criteria

• •1. AML transformed with chronic myelogenous leukemia.
• •2. Acute promyelocytic leukemia (type M3).
• •3. Patients with a second malignancy requiring treatment.
• •4. Patients with uncontrolled active infection.
• •5. Patients with left ventricular ejection fraction \< 0.5 by echocardiography or grade III/IV cardiovascular dysfunction according to the New York Heart Association Classification.
• •6. Patients with hepatic and renal inadequacy: total serum bilirubin \>=2.0 mg/dl, AST \>=3 times ULN, serum creatinine clearance (Ccr) \<50 ml / min.
• •7. Patients with arterial oxygen saturation (SpO 2) was \<95%.
• •8. Patients with HIV infection.
• •9. Patients with active hepatitis B or hepatitis C infection.
• •10. Patients with other commodities that the investigators considered not suitable for the enrollment.